Cargando…

Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3

BACKGROUND: Circular RNAs (circRNAs) have been implicated in the initiation and development of breast cancer as functional non-coding RNAs (ncRNA). The roles of circRNAs as the competing endogenous RNAs (ceRNAs) to sponge microRNAs (miRNAs) have also been indicated. However, the functions of circRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Darbeheshti, Farzaneh, Zokaei, Elham, Mansoori, Yaser, Emadi Allahyari, Sima, Kamaliyan, Zeeba, Kadkhoda, Sepideh, Tavakkoly Bazzaz, Javad, Rezaei, Nima, Shakoori, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201848/
https://www.ncbi.nlm.nih.gov/pubmed/34126989
http://dx.doi.org/10.1186/s12935-021-02015-6
_version_ 1783707879104053248
author Darbeheshti, Farzaneh
Zokaei, Elham
Mansoori, Yaser
Emadi Allahyari, Sima
Kamaliyan, Zeeba
Kadkhoda, Sepideh
Tavakkoly Bazzaz, Javad
Rezaei, Nima
Shakoori, Abbas
author_facet Darbeheshti, Farzaneh
Zokaei, Elham
Mansoori, Yaser
Emadi Allahyari, Sima
Kamaliyan, Zeeba
Kadkhoda, Sepideh
Tavakkoly Bazzaz, Javad
Rezaei, Nima
Shakoori, Abbas
author_sort Darbeheshti, Farzaneh
collection PubMed
description BACKGROUND: Circular RNAs (circRNAs) have been implicated in the initiation and development of breast cancer as functional non-coding RNAs (ncRNA). The roles of circRNAs as the competing endogenous RNAs (ceRNAs) to sponge microRNAs (miRNAs) have also been indicated. However, the functions of circRNAs in breast cancer have not been totally elucidated. This study aimed to explore the clinical implications and possible roles of circ_0044234 in carcinogenesis of the most problematic BC subtype, triple negative breast cancer (TNBC), which are in desperate need of biomarkers and targeted therapies. METHODS: The importance of circ_0044234 as one of the most dysregulated circRNAs in TNBC was discovered through microarray expression profile analysis. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to confirm the downregulation of circ_0044234 in triple negative tumors and cell lines versus non-triple negative ones. The bioinformatics prediction revealed that circ_0044234 could act as an upstream sponge in the miR-135b/GATA3 axis, two of the most dysregulated transcripts in TNBC. RESULTS: Our experimental investigation of circ_0044234 expressions in various BC subtypes as well as cell lines reveals that TNBC expresses circ_0044234 at a substantially lower level than non-TNBC. The ROC curve analysis indicates that it could be applied as a discriminative biomarker to identify TNBC from other BC subtypes. Moreover, circ_0044234 expression could be an independent prognostic biomarker in BC. Interestingly, a substantial inverse expression correlation was detected between circ_0044234 and miR-135b-5p as well as between miR-135b-5p and GATA3 in breast tumors. CONCLUSIONS: The possible clinical usefulness of circ_0044234 as a promising distinct biomarker and upcoming therapeutic target for TNBC have been indicated in this research. Our comprehensive approach revealed the potential circ_0044234/miR135b-5p/GATA3 ceRNA axis in TNBC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02015-6.
format Online
Article
Text
id pubmed-8201848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82018482021-06-16 Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3 Darbeheshti, Farzaneh Zokaei, Elham Mansoori, Yaser Emadi Allahyari, Sima Kamaliyan, Zeeba Kadkhoda, Sepideh Tavakkoly Bazzaz, Javad Rezaei, Nima Shakoori, Abbas Cancer Cell Int Primary Research BACKGROUND: Circular RNAs (circRNAs) have been implicated in the initiation and development of breast cancer as functional non-coding RNAs (ncRNA). The roles of circRNAs as the competing endogenous RNAs (ceRNAs) to sponge microRNAs (miRNAs) have also been indicated. However, the functions of circRNAs in breast cancer have not been totally elucidated. This study aimed to explore the clinical implications and possible roles of circ_0044234 in carcinogenesis of the most problematic BC subtype, triple negative breast cancer (TNBC), which are in desperate need of biomarkers and targeted therapies. METHODS: The importance of circ_0044234 as one of the most dysregulated circRNAs in TNBC was discovered through microarray expression profile analysis. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to confirm the downregulation of circ_0044234 in triple negative tumors and cell lines versus non-triple negative ones. The bioinformatics prediction revealed that circ_0044234 could act as an upstream sponge in the miR-135b/GATA3 axis, two of the most dysregulated transcripts in TNBC. RESULTS: Our experimental investigation of circ_0044234 expressions in various BC subtypes as well as cell lines reveals that TNBC expresses circ_0044234 at a substantially lower level than non-TNBC. The ROC curve analysis indicates that it could be applied as a discriminative biomarker to identify TNBC from other BC subtypes. Moreover, circ_0044234 expression could be an independent prognostic biomarker in BC. Interestingly, a substantial inverse expression correlation was detected between circ_0044234 and miR-135b-5p as well as between miR-135b-5p and GATA3 in breast tumors. CONCLUSIONS: The possible clinical usefulness of circ_0044234 as a promising distinct biomarker and upcoming therapeutic target for TNBC have been indicated in this research. Our comprehensive approach revealed the potential circ_0044234/miR135b-5p/GATA3 ceRNA axis in TNBC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02015-6. BioMed Central 2021-06-14 /pmc/articles/PMC8201848/ /pubmed/34126989 http://dx.doi.org/10.1186/s12935-021-02015-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Darbeheshti, Farzaneh
Zokaei, Elham
Mansoori, Yaser
Emadi Allahyari, Sima
Kamaliyan, Zeeba
Kadkhoda, Sepideh
Tavakkoly Bazzaz, Javad
Rezaei, Nima
Shakoori, Abbas
Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title_full Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title_fullStr Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title_full_unstemmed Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title_short Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
title_sort circular rna hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of gata3
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201848/
https://www.ncbi.nlm.nih.gov/pubmed/34126989
http://dx.doi.org/10.1186/s12935-021-02015-6
work_keys_str_mv AT darbeheshtifarzaneh circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT zokaeielham circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT mansooriyaser circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT emadiallahyarisima circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT kamaliyanzeeba circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT kadkhodasepideh circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT tavakkolybazzazjavad circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT rezaeinima circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3
AT shakooriabbas circularrnahsacirc0044234asdistinctmolecularsignatureoftriplenegativebreastcancerapotentialregulatorofgata3